Sepsis diagnostic panel
SepSeek is designed for rapid pathogen and resistance-marker identification directly from whole blood specimens.
No one should die from a treatable infection.
Delphine Diagnostics is building rapid molecular diagnostics and AI/ML-enabled clinical decision support to help clinicians recognize sepsis risk earlier, identify pathogens and resistance markers sooner, and treat patients with greater precision.
#1Cause of death in U.S.
hospitals
80%Of deaths may be
preventable with timely care
8%Mortality increase for every
hour of delay
350KU.S. deaths per year
attributed to sepsis
Source: US CDC
Uniting rapid pathogen identification with improved risk prediction.
Delphine brings together a sepsis diagnostic panel and ML prediction software to deliver pathogen and resistance-marker identification 6-9 times faster than standard of care, while enabling earlier detection of sepsis risk and smarter treatment decisions.
ML prediction software tool
ClinSight supports earlier sepsis risk detection using clinical features such as vitals, lab results, and observations.
Faster, smarter treatment
Combining diagnostic and decision-support data can reduce uncertainty, support targeted therapy, and improve outcomes.
Faster, targeted treatment can change the patient journey.
Improve and save patient lives
Faster, targeted treatment means a better chance of survival, fewer complications, and safer recovery with less exposure to unnecessary antibiotics.
Reduce diagnostic uncertainty
Rapid answers and early risk signals empower clinicians to intervene sooner, choose the right therapy, and reduce diagnostic uncertainty.
Improve outcomes and lower cost of care
Preventing deterioration and avoiding broad-spectrum overtreatment can reduce high-cost admissions, readmissions, and downstream complications.
Shorten length of stay and improve quality
Earlier detection and optimized antibiotic use can lower ICU burden, shorten length of stay, reduce readmissions, and improve quality metrics.
A connected portfolio for infection diagnosis and treatment support.
Explore Delphine's diagnostic, decision-support, and research-use product areas.
Acinetobacter Baumannii
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More
Delphine AI/ML Healthcare Platform
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More
Delphine Sepsis Diagnostic Assay
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More Escherichia coli
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More
IFU for PathoSeek (RUO Pathogen ID Kits)
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More Klebsiella Pneumoniae
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More
RUO Pathogen Identification Test Kits
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More
Sepsis Prediction Using ML Tool
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read More Staphylococcus Aureus
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer vitae lorem sed arcu facilisis.
Read MoreSepsis Test Workflow Comparison
The SepSeek PCR based assay for bacterial, viral and fungal pathogen identification and resistance biomarkers is 6-9 times faster than conventional blood culture.
Conventional blood culture
Most common turn around time
Conventional blood culture can take 1-7 days for results.
48-72 Hrs
- 01Blood Collection (20ml)
- 02Blood Culture
- 03Bacteria Culture
- 04Bacteria ID
- 05Antimicrobial Sensitivity
- 06Pathogen ID + Resistance
SepSeek PCR based workflow
Most common turn around time
SepSeek results are available in under 8 hours.
6-8 Hrs
- 01Blood Collection (1ml)
- 02DNA Extraction
- 03Multiplex RT-PCR
- 04Data Analysis and Interpretation
- 05Pathogen ID + Resistance
Best-in-class, affordable products for diagnosis and treatment.
Enhance human healthcare.
Our vision is to enhance human healthcare by engaging in the development and supply of best-in-class, affordable products for diagnosis and treatment.
Speed effective diagnosis and treatment.
Delphine Diagnostics, a New Jersey-based startup, is passionate in its efforts to deliver top-tier diagnostic products and supplemental data insights capabilities to speed effective diagnosis and treatment for patients with infectious diseases. The affordability and reliability of our innovative products guide our journey.
Help bring faster sepsis diagnosis closer to the point of care.
Delphine is interested in hearing from future customers, clinical partners, laboratories, and healthcare organizations about diagnostic targets, compatible equipment, and workflow needs.